Product

REBYOTA™

Name

Rebyota

INN Name

Donor Human Stool

FDA Approved

Yes

1 clinical trial

1 organization

1 indication

1 document

Indication

Clostridium Difficile Infection

Clinical trial

REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study

Status: Recruiting, Estimated PCD: 2025-07-07

Document

DailyMed Label: Rebyota

Organization

Ferring Pharmaceuticals Inc.